CLOSE

Specials

  • March
  • BioTech Startups
  • Genomics Europe
  • Bioanalytical Services Europe
  • Sustainable Technologies
  • BioTech Startup APAC
  • Life Science Packaging
  • Europe
  • APAC
  • Bioanalytical Services APAC
  • Life Science Compliance
  • Life Science Analytics
  • Bioanalytical Services
  • September
  • June
  • Contract Research Organization

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
APAC
EUROPE
  • Home
  • News
  • Contributors
  • Magazine
  • Conferences
  • Newsletter
  • About

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Critical Bioanalytical Challenges of ADCs

Critical Bioanalytical Challenges of...

Why Partner with Bioanalysis Experts?

Why Partner with Bioanalysis Experts?

Developing Trends in Biopharma Analysis

Developing Trends in Biopharma Analysis

Invenio Genetics and Imagene Labs Announces Collaboration

Invenio Genetics and Imagene Labs...

Bioanalytical Testing Services and its Market

Bioanalytical Testing Services and...

Korber Widens Its Werum PAS-X MES Service Partner Network

Korber Widens Its Werum PAS-X MES...

Clasado Biosciences Joins Lucie Nagy as Head of Regulatory and Legal

Clasado Biosciences Joins Lucie Nagy...

Reducing the Energy Consumption of Ultra-Low Temperature Freezers

Reducing the Energy Consumption of...

Critical Bioanalytical Challenges of ADCs

Critical Bioanalytical Challenges of...

Why Partner with Bioanalysis Experts?

Why Partner with Bioanalysis Experts?

Developing Trends in Biopharma Analysis

Developing Trends in Biopharma Analysis

Invenio Genetics and Imagene Labs Announces Collaboration

Invenio Genetics and Imagene Labs...

Bioanalytical Testing Services and its Market

Bioanalytical Testing Services and...

Korber Widens Its Werum PAS-X MES Service Partner Network

Korber Widens Its Werum PAS-X MES...

Clasado Biosciences Joins Lucie Nagy as Head of Regulatory and Legal

Clasado Biosciences Joins Lucie Nagy...

Reducing the Energy Consumption of Ultra-Low Temperature Freezers

Reducing the Energy Consumption of...

Importance of Biomarkers in Drug Development

By Life Sciences Review | Friday, April 02, 2021
Tweet

A transformation towards personalized medicine in healthcare has increased biomarker development, and a corresponding accelerates in the complexities and hurdles in biomarker research.


FREMONT, CA: Biomarkers as indicators of biological and pathogenic operations have been leveraged for decades to diagnose patients and prescribe treatment. In the past few years, they’ve substantially transformed drug development practices. The demand for analyzing biomarkers in drug development has risen significantly with the innovation of precision medicine. In drug development, biomarkers that indicate the mechanism of action, target engagement, and clinical results have been deployed to assess both the safety and efficacy of an intervention. More specifically, biomarkers have been leveraged to choose patients for clinical trials, make decisions, help register and label claims, or treat patients.


The number of platforms at disposal to assay biomarkers continues to widen to address different testing hurdles and priorities. It is difficult to select the right platform for the biomarker assay. Among the most common bioanalytical platforms for gauging biomarkers today are ligand-binding assays, flow cytometry, immune histochemistry, and genomics assays. 


Ultimately, several factors go into deciding which methodology to leverage, and researchers must understand both the biological question at hand and the advantages and limitations of each platform.


A good essay requires balancing sensitivity and selectivity. This is specifically true for large molecules in biologic matrices. However, till now, there is no harmonized global biomarker specific analysis/validation guidance. The C-Path White Paper offered the consensus document on best practice methods. However, it only addressed biomarker assay validation for singleplex LBA and immunometric assays, mass spectrometry, and enzyme-based assays. The qualification or validation parameters and acceptance criteria may differ based on the platforms and specific technology, and some may not apply to the qualitative assays.


Given that there is a major increase in biomarkers used to help drug development, best regulatory practices in the laboratories for analyzing biomarkers are forecasted to follow. Outsourcing biomarker research comes with several hurdles, and selecting the right research partner is vital to the success of a complex biomarker project.


Weekly Brief

loading
Towards a New World Order
> <
  • Life Science Compliance 2021

    Top Vendors

    Current Issue
  • Other 2021

    Top Vendors

    Current Issue

Read Also

Genome Sequencing Technology Becoming More Efficient

Genome Sequencing Technology Becoming More Efficient

Contract Research Organization: Top Benefits

Contract Research Organization: Top Benefits

Genomics: How Can Employing AI Enhance Healthcare?

Genomics: How Can Employing AI Enhance Healthcare?

The Potential of Strategic Partnering with CROs

The Potential of Strategic Partnering with CROs
Advantages of Using Glass Pharmaceutical Packaging

Advantages of Using Glass Pharmaceutical Packaging

How Cloud-Based LIMS Helps CROs

How Cloud-Based LIMS Helps CROs

Pharma and Biotech are Looking to Cloud and AI to Expediate Drug Discovery

Pharma and Biotech are Looking to Cloud and AI to Expediate Drug Discovery

What You Should Know About Biotechnology

What You Should Know About Biotechnology
Loading...

Copyright © 2021 Life Science Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/importance-of-biomarkers-in-drug-development--nwid-270.html